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The ﬁrst and most common δ-aminolevulinic
acid dehydratase (ALAD) polymorphism stud-
ied was the Msp single-nucleotide poly-
morphism (SNP) in exon 4. Since it was ﬁrst
reported (Battistuzzi et al. 1981), many reports
(e.g., Onalaja and Claudio 2000) have been
published on its association with inorganic
lead (henceforth referred to as lead).
Epidemiologic studies have tried to determine
if the Msp polymorphism is important in
human susceptibility to lead regarding various
lead-targeted systems (Alexander et al. 1998;
Bergdahl et al. 1997; Hu et al. 2001; Schwartz
et al. 1995, 2000). 
In recent years, reports have been published
on the association between the Msp SNP and
renal effects of lead exposure. Smith et al.
(1995) suggested that the Msp-2 variant is a
more susceptible allele because Msp-2 carriers
had higher concentrations of blood uric acid
and blood urea nitrogen (BUN). The differ-
ences achieved only borderline signiﬁcance after
adjusting for potential confounders. Bergdahl
et al. (1997) found that serum creatinine is
higher for Msp-2 carriers than for Msp 1-1
homozygotes in a sample of 89 lead workers. A
linear relationship was observed between patella
lead concentration, using X-ray fluorescence
method, and serum uric acid when patellar lead
passes 15 µg/g bone mineral for Msp-2 carriers,
but the similar linear relation can be seen only
when patella lead was > 101 µg/g bone mineral
for the Msp 1-1 group (Wu et al. 2003). Wu
et al. (2003) postulated that lead toxicity
became apparent at a lower exposure level for
Msp-2 carriers than for Msp 1-1 persons. These
studies suggested that Msp-2 carriers were more
susceptible to lead effects than were Msp 1-1
homozygotes. However, the reports were not
consistent. Some studies had reported that the
Msp-2 variant was associated with higher creati-
nine clearance as well as lower mean serum cre-
atinine and BUN (Weaver et al. 2003).
Renal parameters such as creatinine clear-
ance, BUN, and serum creatinine are insensitive
to renal function changes. As much as 50–70%
of kidney nephrons must be damaged before
variation can be detected (Goyer 1989). The
consensus may not be so clear, however, regard-
ing the effects of lead on the renal system
because no good longitudinal studies have been
conducted to establish the predictive value of
early biologic exposure markers in lead-exposed
workers. Roels et al. (1994) studied 76 male
lead smelter workers and 68 controls matched
for age, gender, socioeconomic state, residence,
and work shift characteristics. Although the
tibia bone lead, blood lead (PbB), and urinary
lead levels of the exposure group were signiﬁ-
cantly higher than those of the control group,
no signiﬁcant differences were observed in either
common and stimulated creatinine clearance.
More recently, however, Weaver et al. (2003)
reported that higher lead levels were associated
with lower BUN and serum creatinine levels
and higher calculated creatinine clearance
among those with the ALAD 1-2 genotype.
Renal parameters such as low-molecular-
weight proteins [e.g., retinol-binding protein,
α1-microglobulin, β2-microglobulin, N-acetyl-
β-D-glucosaminidase (NAG)] representing
proximal tubule injury are considered good
alternatives because early lead-induced
nephropathy usually involves damage of proxi-
mal tubule cell (Nolan and Shaikh 1992). To
date, several studies have shown that these renal
parameters have good correlation with lead
exposure indices. NAG has been found to be
the only marker elevated in early nephropathy
in five studies reviewed by Bernard and
Lauwerys (1989). One study in Japan (Endo
et al. 1993) claimed that urinary α1-micro-
globulin (Uα1m) can be a useful indicator of
renal impairment. A study of 128 lead workers
(Chia et al. 1995) reported that Uα1m appears
to be the most sensitive parameter compared
with urinary β2-microglobulin (Uβ2m) and
urinary retinol-binding protein (URBP).
Another study of environmental lead exposure
in children showed that URBP is increased by
lead with good dose–effect and dose–response
relations with PbB (Bernard et al. 1995).
To date, 111 SNPs have been reported in
the National Center for Biotechnology
Information website (NCBI 2005). But when
we assessed the website in June 2004, 46 SNPs
were reported. What are the relationships of
these 46 SNPs with the renal effect of lead
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We examined six newly identiﬁed polymorphisms in the δ-aminolevulinic acid dehydratase (ALAD)
single-nucleotide polymorphisms (SNPs) to determine if these SNPs could modify the relationship
between blood lead (PbB) and some renal parameters. This is a cross-sectional study of 276 lead-
exposed workers in Vietnam. All workers were measured for PbB, urinary retinol-binding protein
(URBP), urinary α1-microglobulin (Uα1m), urinary β2-microglobulin (Uβ2m), urinary N-acetyl-
β-D-glucosaminidase (NAG), urinary aminolevulinic acid (ALAU), serum α1-microglobulin (Sα1m),
serum β2-microglobulin (Sβ2m), and urinary albumin (Ualb). The six SNPs were Msp and Rsa in
exon 4, Rsa39488 in exon 5, HpyIV and HpyCH4 in intron 6, and Sau3A in intron 12. Analysis of
covariance (ANCOVA) with interaction of PbB × SNPs were applied to examine modifying effect of
the SNPs on the association of renal parameters and PbB, adjusting for potential confounders of age,
gender, body mass index, and exposure duration. HpyCH4 was found to be associated with certain
renal parameters. For HpyCH4 1-1, an increase of 1 µg/dL PbB caused an increase of 1.042 mg/g
creatinine (Cr) Uα1m, 1.069 mg/g Cr Uβ2m, 1.038 mg/g Cr URBP, and 1.033 mg/g Cr Ualb,
whereas in HpyCH4 1-2, an increase of 1 µg/dL PbB resulted in an increase of only 1.009 mg/g Cr
Uα1m, 1.012 mg/g Cr Uβ2m, 1.009 mg/g Cr URBP, and 1.007 mg/g Cr Ualb. HpyCH4 SNP
appeared to modify the lead toxicity to kidney with wild-type allele being more susceptible than vari-
ants. The mechanism for this effect is not clear. Further studies are needed to conﬁrm this observa-
tion. Key words: δ-aminolevulinic acid dehydratase (ALAD), HpyCH4, intron, lead, SNP
(single-nucleotide polymorphism), urinary albumin (Ualb), urinary retinol-binding protein (URBP),
urinary α1-microglobulin (Uα1m), urinary β2-microglobulin (Uβ2m). Environ Health Perspect
113:1313–1317 (2005). doi:10.1289/ehp.7904 available via http://dx.doi.org/ [Online 1 June 2005]exposure? We used the Helix Tree software
(Golden Helix, Inc., Bozeman, MT, USA;
http://www.goldenhelix.com/pharmhelix
treefeatures.html) to test for linkage disequi-
librium among the 46 SNPs; 6 SNPs were
shown not to be in linkage disequilibrium. In
this study we examined these 6 SNPs (Msp and
Rsa in exon 4, Rsa39488 in exon 5, HpyIV and
HpyCH4 in intron 6, Sau3A in intron 12) and
examined their association with certain renal
functions among a group of lead-exposed
workers in Vietnam.
Materials and Methods
Study population. The study population
consisted of 323 workers from a battery factory
in Hai Phong City, Vietnam. All workers
from the production line as well as in the divi-
sion of management and quality control were
recruited into this study. Of these 323 workers,
246 were occupationally exposed to lead, and
the remaining 77 were not directly exposed to
lead. Although these 77 workers were not
directly exposed to lead, many had a previous
history of exposure. Some were still exposed,
albeit less than the 246 group. Therefore, these
workers were also included in the study.
Signed consent was obtained for each worker
before blood and urine samples were taken for
subsequent analysis. The workers also ﬁlled out
a questionnaire (in Vietnamese) with the help
of a Vietnamese interviewer. After completing
the questionnaire, a spot urine sample and
10 mL of blood were collected from each
worker during the medical examination.
Twenty of the exposed lead workers were not
present during the study period, and 17 did not
want to participate. Of the 77 workers who
were not directly exposed to lead, 10 were
unwilling to give their urine and blood for
analysis. Because the study was strictly on a vol-
untary basis, the workers’ decisions in not giv-
ing urine and/or blood were respected. Hence,
the 47 workers were excluded in the study,
giving a response rate of 88.2% (276 of 323).
Questionnaire. Information gathered
included age, years of education, detailed occu-
pational history, and current and previous
smoking habits. Alcohol intake was also docu-
mented carefully, as it could confound the
ﬁndings. Actual amount of alcohol consump-
tion per day (i.e., types of drink consumed and
the amount estimated by number of bottles
consumed) and number of years of drinking
were noted. Six workers gave a history of dia-
betes mellitus and/or hypertension. These
workers were excluded from the study because
diabetes mellitus and hypertension are known
to affect renal functions.
Laboratory analysis. We obtained blood
samples by venipuncture with lead-free dispos-
able syringes and stored the samples in
heparinized lead-free polypropylene tubes.
PbB was analyzed using atomic absorption
spectrophotometry (Varian Spectra AA-30;
SiberHegner Pte Ltd., Victoria, Australia) with
a graphite furnace. External quality control was
performed yearly under the National External
Quality Assurance Scheme (England) and
Inter-laboratory Comparison Programme
(Canada). We obtained spot urine samples, and
those used for analysis of ALAU, URBP,
Uα1m, Uβ2m, urinary albumin (Ualb), and
NAG were buffered (pH 7.2). Serum and urine
samples were stored at –30°C until analysis. We
analyzed all samples within 1 month of arrival
in Singapore at our laboratory and adjusted all
urine parameters for variability in urine ﬂow
using urinary creatinine that was expressed per
gram of creatinine. Urine creatinine concentra-
tions were determined using standard labora-
tory techniques. Ualb, ALAU, URBP, Uα1m,
Uβ2m, and NAG were measured by enzyme-
linked immunosorbent assay using commer-
cially available polyclonal antibodies or test kits
(Roche Diagnostic Corp., Indianapolis, IN,
USA). The details of these tests have been
reported previously (Green et al. 2004). NAG
was determined using Noto’s method (Chia
et al. 1995)
Identiﬁcation of ALAD polymorphisms. Six
polymorphisms located on the ALAD gene
were selected for analyses in our study. They
are MspI and RsaI polymorphisms, which span
a 248-bp region of the genomic ALAD
sequence, as well as Rsa39488 (232 bp),
HpyIV (234 bp), HpyCH4 (213 bp), and
Sau3AI (282 bp) polymorphisms. The prod-
ucts of interest were determined through
amplification by polymerase chain reaction
(PCR), using primers designed with Primer3
(Whitehead Institute for Biomedical Research,
Cambridge, MA, USA; http://frodo.wi.mit.
edu/cgi-bin/primer3/primer3_www.cgi). The
amplification cycles were performed on the
PTC-100 MJ Thermal Cycler (PerkinElmer,
Inc., Boston, MA, USA) and optimized to
ensure speciﬁc ampliﬁcation of the products of
interest. Each PCR reaction was performed in
a ﬁnal volume of 25 µL, which included 10 ng
of pure genomic DNA, 1.0 µM each primer,
200 µM each dNTP, 1× Taq buffer, 1.5 mM
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Table 1. Demographic characteristics of the study population by SNPs.
Gender Age (years) Exposure (years)
SNP Genotype Male [n (%)] Female [n (%)] n (%) Mean ± SD n Mean ± SD Range
Msp 1-1 168 (92.8) 58 (92.1) 226 (92.6) 39.5 ± 10.6 214 15.4 ± 10.2 1–41
1-2/2-2 13 (7.2) 5 (7.9) 18 (7.4) 36.4 ± 9.8 18 10.8 ± 9.1 1–27
Rsa 1-1 40 (22.1) 16 (26.2) 56 (23.1) 39.8 ± 11.0 54 15.8 ± 11.2 1–41
1-2 86 (47.5) 28 (45.9) 114 (47.1) 38.4 ± 10.3 107 14.3 ± 9.9 1–39
2-2 55 (30.4) 17 (27.9) 72 (29.8) 39.7 ± 10.7 69 15.0 ± 9.9 1–36
Rsa39488 1-1 41 (23.0) 15 (23.8) 56 (23.2) 40.0 ± 11.0 55 16.0 ± 11.3 1–41
1-2 81 (45.5) 32 (50.8) 113 (46.9) 39.3 ± 10.2 105 14.9 ± 10.0 1–39
2-2 56 (31.5) 16 (25.4) 72 (29.9) 39.0 ± 10.7 69 14.5 ± 9.5 1–36
HpyCH4 1-1 136 (87.2) 55 (91.7) 191 (88.4) 39.2 ± 10.4 184 15.5 ± 10.2 1–41
1-2 20 (12.8) 5 (8.3) 25 (11.6) 40.9 ± 10.7 23 13.9 ± 9.3 1–30
HpyIV 1-1 131 (74.9) 42 (67.7) 173 (73.0) 39.8 ± 10.4 163 15.3 ± 10.2 1–41
1-2/2-2 44 (25.1) 20 (32.3) 64 (27.0) 38.1 ± 10.9 62 14.4 ± 10.3 1–39
Sau3A 1-1 106 (66.7) 31 (51.7) 137 (62.6) 38.3* ± 10.7 131 14.9 ± 10.1 1–39
1-2/2-2 53 (33.3) 29 (48.3) 82 (37.4) 41.4* ± 9.7 77 16.05 ± 10.0 1–41
*p < 0.05.
Table 2. Frequencies of alleles and genotypes for each SNP [% (n)].
SNP ALAD1 ALAD2 1-1 1-2 2-2
Msp 95.9 4.1 92.6 (226) 6.6 (16) 0.8 (2)
Rsa 46.7 53.3 23.1 (56) 47.1 (114) 29.8 (72)
Rsa39488 46.7 53.3 23.2 (56) 46.9 (113) 29.9 (72)
HpyCH4 94.2 5.8 88.4 (191) 11.6 (25) 0
HpyIV 85.2 14.8 73 (173) 24.5 (58) 2.5 (6)
Sau3A 76.9 23.1 62.6 (137) 28.8 (63) 8.7 (19)
The distribution of genotypes and alleles within each SNP has been proven to follow the Hardy-Weinberg equilibrium.
Table 3. Mean of exposure indices and renal parameters.
Biologic parameter na Mean ± SD Minimum–maximum Range
PbB (µg/dL)b 247 24.4 ± 13.6 2.0–66.9 64.9
ALAU (mg/g Cr) 236 0.95 ± 1.55 0.34–3.63 3.30
Sα1m (mg/L) 241 41.8 ± 1.29 20.84–74.25 53.42
Sβ2m (mg/L) 244 1.45 ± 1.31 0.77–2.85 2.09
NAG (U/g Cr)c 236 2.82 ± 0.18 0.10–7.60 7.50
Uα1m (mg/g Cr) 244 6.82 ± 1.91 1.29–27.32 26.03
Ualb (mg/g Cr) 239 7.06 ± 1.73 1.23–34.12 32.89
Uβ2m (mg/g Cr) 237 0.19 ± 2.30 0.02–1.81 1.79
URBP (mg/g Cr) 239 0.16 ± 1.95 0.03–0.86 0.83
Cr, creatinine. Data are geometric mean, except as indicated. 
aNumbers differ between tests because some samples were too small for all the tests to be performed. bArithmetic mean.
cSquare root mean.MgCl2, and 1.0 U of Taq DNA polymerase
(all from Promega Corp., Madison, WI, USA),
and topped up to the required volume with
sterile distilled water. We used the restriction
fragment length polymorphism method to
locate the site of mutation; the fragments were
determined on a 2.0% agarose gel (Seakem
agarose; Cambrex North Brunswick Inc.,
North Brunswick, NJ, USA) and visualized on
the Biorad Gel Doc 2000 system(BioRad
Laboratories, Hercules, CA, USA).
Statistical analysis. We determined that
28 people did not have any genotype measure-
ments and had to exclude them from the
analysis, leaving a sample of 248 workers. The
data set of these 248 workers was used in all
subsequent analyses. For some of the biologic
samples, we were not able to analyze all the
parameters because these samples ran out
before we could complete the test.
The distributions of variables were checked
individually with histogram and one-sample
Kolmogorov-Smirnov (K-S) test for normality.
Necessary transformation was undertaken to
achieve normal distribution for all important
variables. In the end, ALAU, Uα1m, Uβ2m,
Ualb, URBP, serum α1-microglobulin (Sα1m),
and serum β2-microglobulin (Sβ2m) went
through logarithmic transformation. NAG
went through square root transformation. The
transformed variables all follow normal
distribution with an insigniﬁcant p-value from
the one-sample K-S test.
Statistical analysis addressed two issues:
a) Is there any difference in the mean PbB
concentrations and renal parameters between
genotypes of each SNP after adjusting for
known confounders? b) Within each single
SNP, is the effect of PbB concentration on the
renal parameters similar across genotype sub-
groups? Analysis of covariance (ANCOVA;
Kutner et al. 2003) was the main statistical
technique used. We initially examined scatter
plots of each renal parameter (y-axis trans-
formed value) and PbB concentration (x-axis)
to identify linearity and extreme points.
We addressed the first issue using
ANCOVA to adjust for age, exposure dura-
tion, body mass index (BMI), PbB (where
appropriate), and gender. For the second issue,
an interaction term of PbB × SNP was
included while adjusting for the known con-
founders. Multiply linear regression equation
models were used in the generation of regres-
sions lines for Figures 1–4. All data are
processed by SPSS (version 12.0; SPSS Inc.,
Chicago, IL, USA). Signiﬁcance level was set as
p < 0.05 (two-sided).
Results
Of the 248 workers, 184 (74.2%) were male
and 64 (25.8%) were female, with a mean age
of 39 (range, 20–66) years. The range of expo-
sure duration was 1–41 years. Demographic fea-
tures by SNP are summarized in Table 1. The
allelic and genotypic frequencies are summarized
in Table 2. For Msp, Sau3A, HpyIV, and
HpyCH4, the wild-type allele is more predomi-
nant, whereas for Rsa and Rsa39488, the variant
allele is more prevalent. The basic characteristics
of the measurement variables are shown in
Table 3. Table 4 shows the comparison of mean
renal parameters by SNPs. The HpyIV variant
group had higher mean ALAU and Ualb levels
than the group with the wild-type genotype
(1.15 vs. 0.95 mg/g Cr and 7.75 vs. 7.37 mg/g
Cr, respectively). The wild-type genotype group
for the Sau3A marker (1-1) had lower ALAU
levels compared with those of the variant group
(0.93 vs. 1.08 mg/g Cr) but higher NAG con-
centrations (2.93 vs. 2.53 U/g Cr). Only
Rsa39488 subgroups had signiﬁcant differences
in PbB, with means of ALAD 1-1, ALAD 1-2,
and ALAD 2-2 being 21.87µg/dL, 20.43µg/dL,
and 25.54 µg/dL, respectively. The group with
the Rsa39488 variant genotype, 2-2, had much
higher PbB levels than the 1-1 and 1-2 geno-
type groups (Table 4).
Multiple linear regression equation models
were constructed for each of the six SNPs. Of
these six SNPs, only HpyCH4 showed signiﬁ-
cant association with URBP, Uα1m, and
Uβ2m in the multiple regression analysis.
Table 5 shows the relationship between differ-
ent renal parameters and the HpyCH4 SNP.
PbB concentrations signiﬁcantly affect URBP,
Uα1m, Uβ2m, and Ualb even after adjusting
for age, gender, BMI, and exposure duration.
PbB is an important predictor for these renal
indices. There are significant interactions
between the HpyCH4 marker and PbB con-
centration (Table 5). The associations of PbB
concentrations and renal parameters are pre-
sented in Figures 1–4.
The increment in renal parameters
corresponding to unit increase in PbB concen-
tration is higher for HpyCH4 1-1 homozy-
gotes than for HpyCH4 1-2 workers. For
Uα1m, each increase of 1 µg/dL PbB corre-
sponds to an increase of 0.016 log Uα1m (anti-
log 1.042 mg/g Cr) for HpyCH4 1-1 workers,
whereas for HpyCH4 1-2 workers the increase 
is 0.004 (anti-log 1.009 mg/g Cr). The same
trend is shown in the relations of Uβ2m,
URBP, and Ualb to PbB concentrations. The
contrast between HpyCH4 1-1 and HpyCH4
1-2 is 1.069 versus 1.012 mg/g Cr, 1.038 versus 
1.009 mg/g Cr, and 1.033 versus 1.007 mg/g
Cr for Uβ2m, URBP, and Ualb, respectively.
ALAD polymorphism and susceptibility to lead toxicity
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Table 4. Mean exposure indices and renal parameters by SNP genotypes.
HpyCH4 HpyIV Msp Rsa Rsa39488 Sau3A
Adjusted mean
a 1-1 1-2 1-1 1-2/2-2 1-1 1-2/2-2 1-1 1-2 2-2 1-1 1-2 2-2 1-1 1-2/2-2
PbB (µg/dL)b 22.68 17.89 23.32 20.52 22.68 17.89 21.13 21.89 24.22 21.87* 20.43* 25.54* 23.22 20.8
ALAU (mg/g Cr) 1 1 0.954** 1.150** 1.01 0.95 1.07 0.98 0.99 1.03 1.02 0.96 0.93** 1.08**
Sα1m (mg/L) 42.02 43.9 42.32 42.02 42.21 40.97 42.23 41.99 42.24 42.29 42.04 42.58 42.04 42.6
Sβ2m (mg/L) 1.41 1.43 1.4 1.4 1.41 1.49 1.36 1.43 1.4 1.37 1.42 1.46 1.4 1.39
NAG (U/g Cr)c 2.81 2.46 2.78 2.77 2.77 2.76 3.12 2.73 2.66 3.07 2.81 2.51 2.93* 2.53*
URBP (mg/g Cr) 0.15 0.13 0.15 0.15 0.15 0.14 0.16 0.14 0.14 0.16 0.14 0.14 0.15 0.14
Uβ2m (mg/g Cr) 0.18 0.21 0.18 0.19 0.18 0.24 0.18 0.19 0.18 0.18 0.17 0.2 0.18 0.18
Ualb (mg/g Cr) 7.35 6.92 7.374* 7.750* 7.29 7.19 7.37 6.84 8.1 7.55 6.98 7.79 7.6 6.79
Uα1m (mg/g Cr) 6.21 5.29 6.15 6.07 6.11 6.8 6.49 5.69 6.58 6.5 5.72 6.53 5.89 6.36
Data are geometric means adjusted for age, exposure duration, gender, BMI, and PbB, unless otherwise speciﬁed.
aAdjusted for age, exposure duration, gender, and BMI. bArithmetic mean. cSquare root mean. *p < 0.05. **p < 0.01.
Table 5. Models of HpyCH4 regression by renal
parameters.
Variable β (95% CI) p-Values
Log URBP
R2 = 0.1473
PbB 0.016 (0.006, 0.027) 0.002
HpyCH4 –0.02 (–0.140, 0.100) 0.742
HpyCH4 × PbB –0.012 (–0.022, –0.003) 0.008
Log Uα1m
R2 = 0.2366
PbB 0.018 (0.008, 0.027) < 0.001
HpyCH4 –0.067 (–0.177, 0.043) 0.233
HpyCH4 × PbB –0.014 (–0.022, –0.005) 0.002
Log Uβ2m
R2 = 0.1417
PbB 0.029 (0.016, 0.042) < 0.001
HpyCH4 0.047 (–0.103, 0.197) 0.537
HpyCH4 × PbB –0.024 (–0.035, –0.012) < 0.001
Log Ualb
R2 = 0.1417
PbB 0.014 (0.005, 0.023) 0.002
HpyCH4 0.000 (–0.103, 0.103) 0.998
HpyCH4 × PbB –0.011 (–0.019, –0.003) 0.007
CI, conﬁdence interval. 
The model adjusts for age, gender, BMI, and exposure dura-
tion. 0 represents the HpyCH4 1-1; 1 represents HpyCH4 1-2.
The reference group is HpyCH4 1-1; the β-coefﬁcient of PbB
is the slope for the association between PbB and renal para-
meters in participants with this genotype. The corresponding
slope in workers with ALAD 1-2 is the sum of the β-coefﬁcient
of PbB and that of HpyCH4 × PbB in each model (i.e., in the
URBP model, the β-coefﬁcient of PbB for HpyCH4 1-1 group is
0.016; the corresponding β for HpyCH4 1-2 is 0.004 = 0.016 +
–0.012). p-Values for the HpyCH4 × PbB reﬂect the statistical
significance of the difference between the slopes of the
regression line for HpyCH4 1-1 and for HpyCH4 1-2 workers.Discussion
For ALAD SNPs, this study is the first to
address more than one SNP. In addition to
Msp in exon 4, we also examined Rsa SNP in
exon 4, Rsa39488 in exon 5, HpyCH4 and
HpyIV in intron 6, and Sau3A in intron 12. It
has been shown by linkage analyses that these
six SNPs are not in linkage disequilibrium.
We did not find any correlation of lead
with Sα1m or Sβ2m, which is consistent with
other studies (Cardenas et al. 1993; Chia et al.
1994; Endo et al. 1993). In our study, Msp
SNP in exon 4 constitutes 95.9% of ALAD1
and 4.1% of ALAD2 alleles. This pattern is
similar to those in most studies conducted on
Asian populations (Hsieh et al. 2000; Shen
et al. 2001). The allele composition of the other
five SNPs had not been reported. To our
knowledge, this is the ﬁrst report of genetic dis-
tribution of the ALAD polymorphism in a
Vietnamese population.
Although we determined some positive
findings with Rsa, Rsa39488, HpyIV, and
Sau3A, our findings were not consistent.
Therefore, these SNPs are not discussed further;
we concentrate our discussion on HpyCH4 and
its association with renal function. HpyCH4 is a
SNP that involves a G/C transversion in gene
position 12,916 in intron 6. This SNP was ﬁrst
reported by Olson (2000). Allele frequency in
his sample (North American population)
was 0.818 for HpyCH4-1 and 0.182 for
HpyCH4-2, and genotype frequency is 0.727
for HpyCH4 1-1, 0.182 for HpyCH4 1-2, and
0.091 for HpyCH4 2-2. Nakamura (2002)
reported the frequencies of HpyCH4-1 to be
0.808 and of HpyCH4-2 to be 0.191 in a sam-
ple of 734 Japanese. In our study, HpyCH4-1
has a frequency of 0.942, and HpyCH4-2 has a
frequency of 0.058. HpyCH4 1-1 homozygotes
accounted for 88.4% (191), HpyCH4 1-2
heterozygotes accounted for 11.6% (25).
Variant HpyCH4 2-2 homozygotes were not
detected in this study population. Our study
frequencies of the HpyCH4 allele were fairly
similar to those reported by Nakamura (2002),
whose sample was also drawn from an Asian
population. However, the proportion of
HpyCH4-1 in our study was relatively higher.
Several studies have shown that URBP
(Bernard et al. 1995), Uα1m (Chia et al.
1995; Endo et al. 1993), Uβ2m (Nolan and
Shaikh 1992), and urinary NAG (Bernard and
Lauwerys 1989) are good indicators of early
renal effects due to lead exposure. A study of
128 lead workers in Singapore (Chia et al.
1995) showed that Uα1m appears to be the
most sensitive parameter compared with
Uβ2m and URBP.
Our study found that a newly identified
ALAD polymorphism, HpyCH4 in intron 6,
was able to modify the association of PbB con-
centrations with certain renal parameters. For
HpyCH4 1-1 homozygotes, 1 µg/dL PbB
caused an increase of 1.042 mg/g Cr Uα1m,
1.069 mg/g Cr Ub2m, 1.038 mg/g Cr URBP,
and 1.033 mg/g Cr Ualb, whereas in HpyCH4
1-2 heterozygotes, an increase of 1 µg/dL PbB
resulted in an increase of only 1.009 mg/g Cr
Uα1m, 1.012 mg/g Cr Uβ2m, 1.009 mg/g Cr
URBP, and 1.007 mg/g Cr Ualb. These ﬁnd-
ings suggest that the HpyCH4 1-2 variant could
be more resistant to the effects of lead toxicity
on some renal functions than HpyCH4 1-1.
We showed that in the relationship
between PbB and some renal parameters
(Figures 1–4), two regression lines (HpyCH4
1-1 and HpyCH4 1-2) intersect around
25 µg/dL PbB. This point highlights the
importance of stratifying the data by PbB
when we study the modification effects of
ALAD polymorphism on associations between
lead exposure and renal function. Otherwise,
problems would arise and cause bias in the
ﬁndings. In our study, for workers with PbB
< 25 µg/dL, HpyCH4 2-2 workers have higher
renal function values than HpyCH4 1-1 work-
ers. The opposite is true for workers with
PbB > 25 µg/dL. Thus, one may conclude that
ALAD2 is more susceptible when the samples
have low lead exposure. Conversely, one
might find that ALAD1 is more susceptible
when the samples have higher exposure (i.e.,
PbB > 25 µg/dL). Our ﬁndings may explain, to
some degree, why there were contradicting
reports on the association between PbB concen-
trations and ALAD alleles in some studies.
Wetmur et al. (1991) found a signiﬁcant over-
representation of Msp-2 isozymes among indi-
viduals with PbB in excess of 30 µg/dL.
Schwartz et al. (1995) reported that the over-
representation of Msp-2 allele can be present
only when the PbB was > 40 µg/dL. Smith
et al. (1995) failed to show any association of
Msp-2 to PbB and he ascribed the nonassocia-
tion with the low lead exposure of the study
population (mean PbB, 7.78 µg/dL).
For the Msp polymorphism, the differences
noted in relation to the susceptibility of effects
Chia et al.
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Figure 1. Regression lines of Uβ2m versus PbB by
HpyCH4 genotype, adjusted for age, exposure dura-
tion, gender, and BMI. Data points are speciﬁed by
value pairs of blood lead (PbB) and log-transformed
renal parameters (Uα1m, Uβ2m, URBP, Ualb). 
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Figure 2. Regression lines of URBP versus PbB by
HpyCH4 genotype adjusted for age, exposure dura-
tion, gender, and BMI. 
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Figure 3. Regression lines of Uα1m versus PbB by
HpyCH4 genotype adjusted for age, exposure dura-
tion, gender, and BMI. 
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Figure 4. Regression lines of Ualb versus PbB by
HpyCH4 genotype adjusted for age, exposure dura-
tion, gender, and BMI. 
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HpyCH4 1-2 heterozygotesof lead have been attributed to the differential
binding abilities of the ALAD isozymes.
However, the HpyCH4 SNP, located in the
intron region of the ALAD gene, technically
does not have any protein-coding functions
involved. George and David (1998) observed
that some DNA behaves as an exon when
expressed by one pathway but as an intron
when expressed by another pathway. Both
pathways can operate simultaneously, resulting
in greater protein product variety. Perhaps the
ALAD enzyme encoded by HpyCH4 1-1 and
HpyCH4 1-2 could have been produced
through one such pathway (George and David
1998). Regulatory functions of introns may
involve controlling gene activity in different
developmental stages or responding to immedi-
ate biologic needs by controlling local gene
expressions. This function of introns could
occur if exons code for a domain, a polypeptide
unit that has a discrete function such as binding
to a membrane, the catalytic site of an enzyme,
or a structural unit of a protein (Jerry 2001).
However, few studies have reported that poly-
morphisms located in introns can be associated
with lead toxicity. One study that examined
Msp polymorphism in intron 2 reported that
variant workers were associated with decreased
bone lead but not PbB (Kamel et al. 2003).
Recent work has demonstrated that intronic
mutations can have functional consequences in
some genes such as p53 (Lehman et al. 2000).
Similarly, intronic mutations may also have
functional consequences in the ALAD genes.
Some limitations are inherent in this
study. It is possible that individuals with cer-
tain ALAD polymorphisms may be more sus-
ceptible to the effects of lead toxicity on the
renal system and thus would have been
excluded from the workforce even before this
study was conducted (healthy worker effect).
But these susceptible workers will need to
have obvious clinical renal diseases to be
removed from the workforce. This is first
time that factory workers in Vietnam were
tested with these renal tests. Therefore, it is
highly unlikely that we are dealing with a
healthy worker effect. In Vietnam, most fac-
tories are state owned, as is this factory.
Workers work in a factory all their lives (as
can be seen by the long exposure history in
Table 1). Schwartz et al. (1995) reported dif-
ferences in the Msp ALAD genotype frequen-
cies among workers in three lead factories
with different lead exposures. They postulated
that workers with the more susceptible ALAD
genotype may moved to a lower lead-exposed
job. Conversely, workers with the protective
ALAD genotype may continue working
because they have fewer symptoms even in
higher exposure areas. We are unable to study
this possible “population stratification” bias
because our workers were rotated through the
different departments/sections in the factory
depending on the job schedule and man-
power requirement.
We did not measure the body burden of
lead and thus could not examine the effects of
the ALAD SNPs in relation to lead accumula-
tion in the body. We did use exposure duration
as a surrogate, and this factor has been adjusted
for in our analysis. In spite of factoring in the
duration of exposure to lead, workers with
HpyCH4 1-2 genotype had signiﬁcantly better
renal (certain) parameters than workers with
the HpyCH4 1-1 genotype. The sample size of
our study is also not large. There were only
25 workers with HpyCH4 1-2 compared with
191 workers with HpyCH4 1-1. Cadmium is
also known to affect some of the renal parame-
ters that were measured in this study (Chia
et al. 1989). It has been reported that urinary
cadmium of 4 µg/g Cr is the critical value for
cadmium to have a signiﬁcant effect on Uα1m,
Uβ2m, URBP, and NAG (Roels et al. 1993).
There was no measurement of cadmium levels
for all the workers. However, we randomly
selected a sample of 25 workers and determined
their urine cadmium level; the mean was
0.57 µg/g Cr with a range of 0.34–0.98 µg/g
Cr. These values were far below the reported
urinary cadmium of 4 µg/g Cr that would
affect some of the studied renal parameters.
In conclusion, HpyCH4 SNP located in
intron 6 may have modifying effects on the
relationship between lead exposure and renal
function, with individuals carrying the
HpyCH4 1-1 genotype being more susceptible
to lead toxicity of the kidneys. The mechanism
for this is unclear. Further studies are needed
to conﬁrm this observation.
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